AU Patent

AU2013206229B2 — A method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions

Assigned to Allergan Sales LLC · Expires 2015-12-10 · 10y expired

What this patent protects

The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical 5 compositions. "10 ---- --r 14 - - -- ----- --- -- ------ ~z ------- ------- V12 v5

USPTO Abstract

The invention relates to a method for treating overactive bladders and a device for storing and administering non-occluded oxybutynin topical 5 compositions. "10 ---- --r 14 - - -- ----- --- -- ------ ~z ------- ------- V12 v5

Drugs covered by this patent

Patent Metadata

Patent number
AU2013206229B2
Jurisdiction
AU
Classification
—
Expires
2015-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Sales LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.